Latest Tax Refunds News

Page 10 of 23
Commonwealth Bank of Australia reported a 5% rise in net profit for the half-year ended December 2025, balancing lending growth with margin pressures and increased technology investment.
Victor Sage
Victor Sage
11 Feb 2026
Delorean Corporation has completed the $53 million Yarra Valley Water bioenergy facility and progressed key projects in South Australia and Victoria, supported by strong government grants and renewable gas policies.
Victor Sage
Victor Sage
30 Jan 2026
Australian Rare Earths Limited (ASX – AR3) has made significant strides in advancing its Koppamurra Rare Earths Project, securing pilot-scale processing at ANSTO’s new facility and raising $6 million post-quarter to fund development. Concurrently, promising uranium targets have been identified at its Overland Project.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Vectus Biosystems is close to finalising a $4.3 million transaction with Canadian biotech XORTX Therapeutics, while actively pursuing licensing opportunities for its anti-fibrotic drug candidates amid cost reductions.
Ada Torres
Ada Torres
30 Jan 2026
Mithril Silver and Gold Limited reports strong exploration progress at its Copalquin project in Mexico, with resource expansion drilling underway and a new acquisition adding to its portfolio. The company ends the quarter with a robust cash position, setting the stage for an active 2026.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Papyrus Australia has taken a significant step towards commercialisation with a $4.2 million supply contract and the near completion of its Adelaide Rapid Prototyping and R&D Facility.
Victor Sage
Victor Sage
30 Jan 2026
Prescient Therapeutics has secured a key regulatory milestone with the EMA granting Orphan Drug Designation for PTX-100 to treat cutaneous T-cell lymphoma, while expanding its Phase 2a clinical trial across multiple continents.
Ada Torres
Ada Torres
30 Jan 2026
Nimy Resources has announced a maiden JORC Inferred Resource for high-grade gallium and rare earth elements at its Mons Project in Western Australia, marking a significant step towards becoming a key supplier in critical minerals.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Sparc Technologies has marked a significant milestone with sustained hydrogen production at its pioneering pilot plant and secured key patents, while also achieving its first commercial sale of graphene additives.
Victor Sage
Victor Sage
30 Jan 2026
Neurotech International has secured a Rare Pediatric Disease Designation from the FDA for its lead drug NTI164 targeting Rett syndrome, alongside publishing promising clinical data and raising $8.7 million to fuel further development.
Ada Torres
Ada Torres
30 Jan 2026
AdAlta Limited has launched its 'East to West' cellular immunotherapy operations through a strategic collaboration with Shanghai Cell Therapy Group to co-develop BZDS1901, an innovative CAR-T therapy targeting mesothelioma and other solid cancers. The company also strengthened its balance sheet by raising $2.8 million via private placements and repaying key investment agreements.
Ada Torres
Ada Torres
30 Jan 2026
Spectur Limited reported a 4.5% increase in quarterly revenue to $2.02 million and secured $2.15 million through a share placement to fund its AI-driven Sense-Think-Act platform development.
Sophie Babbage
Sophie Babbage
30 Jan 2026

Browse the archive

Full archive